FOXM1 and colorectal carcinoma: FOXM1 also affects radiotherapy outcomes in many cancer types, including CRC (Kwon et al., 2021; Li et al., 2022; Liu et al., 2019; Pal et al., 2018; Takeshita et al., 2023; Xiu et al., 2018).